Semin Thromb Hemost 2003; 29(6): 567-574
DOI: 10.1055/s-2004-815624
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Arterial Ischemic Strokes in Infants and Children: An Overview of Current Approaches

Gabrielle deVeber
  • Associate Professor, Children's Stroke Program, Department of Pediatrics, University of Toronto, Ontario, Canada.
Further Information

Publication History

Publication Date:
13 January 2004 (online)

ABSTRACT

Stroke in children is increasingly recognized. The incidence exceeds 8 per 100,000 per year. Important differences in stroke in newborns and children compared with adults, as well as a paucity of clinical trials, create challenges in the diagnosis and management of pediatric arterial ischemic stroke (AIS).

The neurological presentation of AIS can be subtle. Radiographic diagnosis of acute AIS is also challenging because CT scan may be normal early on. Risk factors include vascular, intravascular, and embolic disorders; frequently, there are multiple risk factors in a given child, necessitating thorough investigations. More than 50% have a vasculopathy including postvaricella angiopathy, dissection, moyamoya, or vasculitis. Intravascular mechanisms are frequently present, including dehydration. Hematological or prothrombotic conditions are also associated with AIS in children, and include sickle cell disease and prothrombotic disorders. The latter have been identified in from one third to one half of children with AIS, are usually acquired, and frequently act in concert with other risk factors for stroke. The most common embolic source is congenital heart disease, which is present in 25% of children with AIS.

Outcomes include death in 6% and neurological deficits in two thirds of children. Given that no clinical trials have been completed in pediatric stroke to date, treatment is empiric. Initial neuroprotective strategies aim to reduce the size of the infarct. For older children antithrombotic agents (antiplatelet drugs and anticoagulants) are given to reduce the 20 to 30% risk of recurrence. There are coordinated research efforts currently being initiated, which over the next decade will result in clinical trials in this understudied condition.

REFERENCES

  • 1 Lynch J, Hirtz D, deVeber G, Nelson K. Report of the national institute of neurological disorders and stroke workshop on perinatal and childhood stroke.  Pediatrics . 2002;  109 16-23
  • 2 Ball Jr S W. Cerebrovascular occlusive disease in childhood.  Neuroimaging Clin North Am . 1994;  4 393-421
  • 3 Koelfen W, Freund M, Konig S, Varnolt V, Rohr H, Schultz C h. Results of parenchymal and angiographic magnetic resonance imaging and neuropsychological testing of children after stroke as neonates.  Eur J Pediatr . 1993;  152 1030-1035
  • 4 Wiznitzer M, Masaryk T J. Cerebrovascular abnormalities in pediatric stroke: assessment using parenchymal and angiographic magnetic resonance imaging.  Ann Neurol . 1991;  29 585-589
  • 5 Murphy S L. Deaths: Final Data for 1998. National Vital Statistic Reports. Hyattsville, MD: National Center for Health Statistics 2000
  • 6 Taylor T N, Davis P H, Torner J C, Holmes J, Meyer J W, Jacobson M F. Lifetime cost of stroke in the United States.  Stroke . 1996;  27 1459-1466
  • 7 Roach R S, Riela A R. Pediatric Cerebrovascular Disorders, 2nd ed.  New York: Futura Publishing 1995
  • 8 Roach E, deVeber G, Kirkham F. Knowledge of consequences: understanding stroke in children.  J Child Neurol . 2000;  15 277-278
  • 9 deVeber G, Roach E S, Riela A R, Wiznitzer M. Stroke in children: recognition, treatment, and future directions.  Semin Pediatr Neurol . 2000;  7 309-317
  • 10 deVeber G. Cerebrovascular diseases in children. In: Swaiman KF, Ashwal S, eds. Pediatric Neurology: Principles and Practice St. Louis: Mosby 1999: 1099-1124
  • 11 Kerr L M, Anderson D M, Thompson J A, Lyver S M, Call G K. Ischemic stroke in the young: evaluation and age comparison of patients six months to thirty-nine years.  J Child Neurol . 1993;  8 266-270
  • 12 deVeber G, The Canadian Pediatric Ischemic Stroke Study Group. Canadian paediatric ischemic stroke registry: analysis of children with arterial ischemic stroke [abstract].  Ann Neurol . 2000;  48 526
  • 13 Estan J, Hope P. Unilateral neonatal cerebral infarction in full term infants.  Arch Dis Child Fetal Neonatal Ed . 1997;  76 F88-F93
  • 14 Levy S R, Abroms I F, Marshall P C, Rosquete E E. Seizures and cerebral infarction in the full-term newborn.  Ann Neurol . 1985;  17 366-370
  • 15 Gabis L V, Yangala R, Lenn N J. Time lag to diagnosis of stroke in children.  Pediatrics . 2002;  110 924-928
  • 16 Lanska M, Lanska D, Horwitz S, Aram D. Presentation, clinical course, and outcome of childhood stroke.  Pediatr Neurol . 1991;  7 333-341
  • 17 Golomb M R, MacGregor D L, Domi T. et al . Presumed pre- or perinatal arterial ischemic stroke: risk factors and outcomes.  Ann Neurol . 2001;  50 163-168
  • 18 Bouza H, Rutherford M, Acolet D, Pennock J M, Dubowitz L M. Evolution of early hemiplegic signs in full term infants with unilateral brain lesions in the neonatal period: a prospective study.  Neuropediatrics . 1994;  25 201-207
  • 19 deVeber G, MacGregor D, Curtis R, Mayank S. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis.  J Child Neurol . 2000;  15 316-324
  • 20 Trescher W. Ischemic stroke syndromes in childhood.  Pediatr Ann . 1992;  21 374-382
  • 21 Ganesan V, Prengler M, McShane M A, Wade A, Kirkham F J. Investigation of risk factors in children with arterial ischemic stroke.  Ann Neurol . 2003;  53 167-173
  • 22 Lanthier S, Carmant L, David M, Larbrisseau A, de Veber G. Stroke in children: the coexistence of multiple risk factors predicts poor outcome.  Neurology . 2000;  54 371-378
  • 23 Andrew M, deVeber G. Pediatric Thromboembolism and Stroke Protocols.  Hamilton, Ontario: Decker; 1999
  • 24 Chabrier S, Rodesch G, Lasjaunias P, Tardieu M, Landrieu P, Sebire G. Transient cerebral arteriopathy: a disorder recognized by serial angiograms in children with stroke.  J Child Neurol . 1998;  13 27-32
  • 25 Askalan R, Laughlin S, Mayank S. et al . Chickenpox and stroke in childhood: a study of frequency and causation.  Stroke . 2001;  32 1257-1262
  • 26 Sebire G, Meyer L, Chabrier S. Varicella as a risk factor for cerebral infarction in childhood: a case- control study.  Ann Neurol . 1999;  45 679-680
  • 27 Fullerton H J, Johnston S C, Smith W S. Arterial dissection and stroke in children.  Neurology . 2001;  57 1155-1160
  • 28 Borges G, Bonilha L, Santos S F. et al . Thrombosis of the internal carotid artery secondary to soft palate injury in children and childhood. Report of two cases.  Pediatr Neurosurg . 2000;  32 150-153
  • 29 Chabrier S, Husson B, Lasjaunias P, Landrieu P, Tardieu M. Stroke in childhood: outcome and recurrence risk by mechanism in 59 patients.  J Child Neurol . 2000;  15 290-294
  • 30 Feucht M, Brantner S, Scheidinger H. Migraine and stroke in childhood and adolescence.  Cephalagia . 1995;  15 26-30
  • 31 Blau E B, Morris R F, Yunis E J. Polyarteritis nodosa in older children.  Pediatrics . 1977;  60 227-234
  • 32 Lanthier S, Lortie A, Michaud J, Laxer R, Jay V, deVeber G. Isolated angiitis of the CNS in children.  Neurology . 2001;  56 837-842
  • 33 Ikezaki K. Rational approach to treatment of moyamoya disease in childhood.  J Child Neurol . 2000;  15 350-356
  • 34 Hartfield D S, Lowry N J, Keene D L, Yager J Y. Iron deficiency: a cause of stroke in infants and children.  Pediatr Neurol . 1997;  16 50-53
  • 35 Chan A K, deVeber G. Prothrombotic disorders and ischemic stroke in children.  Semin Pediatr Neurol . 2000;  7 301-308
  • 36 Strater R, Becker S, von Eckardstein A. et al . Prospective assessment of risk factors for recurrent stroke during childhood-a 5-year follow-up study.  Lancet . 2002;  360 1540-1545
  • 37 Nelson K B, Dambrosia J M, Grether J K, Phillips T M. Neonatal cytokines and coagulation factors in children with cerebral palsy.  Ann Neurol . 1998;  44 665-675
  • 38 Golomb M R, MacGregor D L, Domi T. et al . Presumed pre-or perinatal arterial ischemic stroke: risk factors and outcomes.  Ann Neurol 2001;50163-50168.
  • 39 Lanthier S, Lindsay S, Mitchel L. et al . Anticardiolipin antibodies are associated with cardioembolic stroke but do not predict recurrent cerebral ischemia in children (in press).  Neurology. 2003; 
  • 40 Brey R L, Hart R G, Sherman D G, Tegeler C H. Antiphospholipid antibodies and cerebral ischemia in young people.  Neurology . 1990;  40 1190-1196
  • 41 Angelini L, Ravelli A, Caporali R, Rumi V, Nardocci N, Martini A. High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia.  Pediatrics . 1994;  94 500-503
  • 42 Domi T, Edgell D, McCrindle B W. et al . Frequency and predictors of vasoocclusive strokes associated with congenital heart disease [abstract].  Ann Neurol . 2002;  52 (suppl 3) S129-S133
  • 43 Monagle P, Cochrane A, McCrindle B, Benson L, Williams W, Andrew M. Thromboembolic complications after Fontan procedures: the role of prophylactic anticoagulation [editorial].  J Thorac Cardiovasc Surg . 1998;  115 493-498
  • 44 Gadian D G, Calamante F, Kirkham F J. et al . Diffusion and perfusion magnetic resonance imaging in childhood stroke.  J Child Neurol . 2000;  15 279-283
  • 45 Strater R, Kurnik K, Heller C, Schobess R, Luigs P, Nowak-Göttl U. Aspirin versus low-dose low-molecular-weight heparin: antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow-up study.  Stroke . 2001;  32 2554-2558
  • 46 Pulsinelli W A, Jacewicz M, Buchan A M. Stroke and hypoxiac-ischemic disorders. In: Johnston MV, Macdonald RL, Young AB, eds. Principles of Drug Therapy in Neurology Philadelphia: FA Davis, 1991: 18-160
  • 47 Ganesan V, Ng V, Chong W K, Kirkham F J, Connelly A. Lesion volume, lesion location, and outcome after middle cerebral artery territory stroke.  Arch Dis Child . 1999;  81 295-300
  • 48 De Schryver L E, Kappelle L J, Jennekens-Schinkel A, Boudewyn Peters C A. Prognosis of ischemic stroke in childhood: a long-term follow-up study.  Dev Med Child Neurol . 2000;  42 313-318
    >